Time and the structuring of ritual performance in the xenotransplantation debate.

Advancements in biotechnology provoke fundamental questions about the relationship of humans to the natural world. A crisis arises as the knowledge, practice, and policies concerning biotechnology grow further out of step with each other. This paper examines the role of ritual performance as a means of resolving this crisis, uniting the organic with the socio-moral aspects of science, technology and regulatory policy. Ritual performance is evident in the public discussions of the United States' Secretary's Advisory Committee on Xenotransplantation (SACX). In an attempt to understand the cultural responses to new knowledge, this paper examines the transcripts of several SACX meetings for its ritual elements and references to authority. We find that time is used by scientists to structure ritual performance in a way that guides public policy and attitudes toward xenotransplantation.

The legacy of nuclear risk and the founder effect in biotechnology organizations.

In the wake of the Chernobyl nuclear accident and a decline in the public trust of science, the founders of modern biotechnology recognized the strategic importance of risk assessment and regulatory affairs. In an effort to avoid the demonization that was attached to the nuclear industry, the pioneers of modern biotechnology delegated authority for regulatory negotiation and risk management to senior positions in the firm. At the same time, the Biotechnology Industry Organization was handed great latitude and trust with making public pronouncements on issues of bioethics and public policy. The way in which founders and leaders embed norms for negotiating regulation and responding to public perceptions has proved important in the maturation and acceptance of a biotechnology sector.